This is a working overview of lyophilized powder, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-08-27 and is reviewed periodically as new material appears.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Modeled on angiotensin IV |
| Common synonyms | PNB-0408; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Research codes vary by supplier |
| Appearance | White to off-white powder | Typical for lyophilized peptides |
| Solubility | Soluble in organic solvents; limited in water | Formulation dependent |
| Typical storage | −20 °C, desiccated, protected from light | Stability depends on purity and container |
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Uranium-232 has a half-life of 68.9 years and is a side product in the thorium cycle. It has been cited as an obstacle to nuclear proliferation using 233U, because the intense gamma radiation from 208Tl (a daughter of 232U, produced relatively quickly) makes 233U contaminated with it more difficult to handle. Uranium-232 is a rare example of an even-even isotope that is fissile with both thermal and fast neutrons.
== Gameplay == Each player controls a base that represent that player's life pool, and is able to obtain another base if theirs is destroyed. The object is to destroy three bases to win the game, which is achieved by attacking the opposing player. On their turn, a player uses the resources from the five cards in their hand to obtain new cards from a central "galaxy row", which contains cards of the Empire and Rebel factions. The player may only select from cards of their faction, and the galaxy row is reconstituted with cards from the "galaxy deck". One innovate game mechanic is the ability of a player to attack cards still in the galaxy row before they have been obtained by other players, known as sabotage for the Rebel faction and bounty hunting for the Empire faction. These provide a reward to the player taking that action, and also deny other players from obtaining targeted cards. Throughout the game, a Force meter records the balance in the Force, which may alter the effect of cards in favour of a particular faction.
=== Queiroz, Rueda and a missed World Cup (2019–2022) === Pékerman stepped down in September 2018 after more than six years in charge, and the former Manchester United assistant and Iran manager Carlos Queiroz was presented as his successor in Bogotá on 7 February 2019. Colombia opened the 2019 Copa América by beating Argentina 2–0 in Salvador, their first win over La Albiceleste since 2007, then beat Qatar 1–0 and Paraguay 1–0 to take nine points from three matches without conceding. Chile eliminated them 5–4 on penalties in the quarter-finals in São Paulo after a goalless draw. Colombia began the 2022 qualifiers with a 3–0 win over Venezuela and a 2–2 draw in Santiago, but form collapsed after the campaign's COVID-19 suspension. A 3–0 home defeat by Uruguay in Barranquilla on 13 November 2020 was followed four days later by a 6–1 loss in Quito. Queiroz departed on 1 December 2020, and on 14 January 2021 the federation announced the return of Reinaldo Rueda.
Sources: en.wikipedia.org
=== Generic names === Anastrozole is the generic name of the drug and its INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name, BANTooltip British Approved Name, and JANTooltip Japanese Accepted Name.
== hCG preparations == Human chorionic gonadotropin (hCG) can be recovered from the urine of pregnant women or be produced from recombinant DNA. It acts similarly to LH, but the larger supply makes it less costly; it also has a longer half-life. In veterinary medicine, equine chorionic gonadotropin (eCG) extracted from pregnant mare serum is used instead on a variety of mammals, sometimes eliciting an immune response in non-horse species. In Women: Used to induce final maturation of follicle and subsequent ovulation. Also used for luteal phase support. In men: Used to treat select cases of Hypogonadotropic Hypogonadism in adult males. In off-label use, some urologists prescribe hCG in low doses in combination with testosterone replacement to preserve fertility. In male children: Also used to treat prepubertal cryptorchidism not due to anatomical obstruction. Therapy is usually administered between ages 4 and 9.
homeobox Any of a class of DNA sequences approximately 180 base pairs in length occurring near the 3'‐end of certain eukaryotic genes and encoding a 60-amino acid domain, known as a homeodomain, which is capable of binding to DNA or RNA via a characteristic helix-turn-helix motif. Homeobox-containing genes are translated into homeodomain-containing proteins, which commonly regulate transcription or translation by binding to other genes or messenger RNAs containing homeobox responsive elements. The products of many homeotic genes, exemplified by the Hox genes, are of critical importance in developmental pathways.
Sources: en.wikipedia.org
=== Orthoesters === An uncommon class of esters are the orthoesters. One of them are the esters of orthocarboxylic acids. Those esters have the formula RC(OR′)3, where R stands for any group (organic or inorganic) and R′ stands for organyl group. For example, triethyl orthoformate (HC(OCH2CH3)3) is derived, in terms of its name (but not its synthesis) from esterification of orthoformic acid (HC(OH)3) with ethanol.
==== Components ==== Water: Water makes up around 80% of cartilage. Chondrocytes: Chondrocytes are the cells that produce and maintain the cartilaginous matrix. They are sparsely dispersed throughout cartilage and make up only about 2% of the total volume of cartilage. Chondrocytes vary in size, shape and concentration depending on their location in articular cartilage. Collagen: Collagen is a structural protein present in the extracellular matrix of cartilage. Collagen is composed of a triple helix structure of polypeptide chains and offers shear and tensile properties to the cartilage. Type II collagen is the most common type of collagen present in cartilage though types IX, X, XI, and XIV are also present. Overall, collagen is a stabilizing protein present in the ECM. Proteoglycans: Proteoglycans are the second most abundant macromolecule in the ECM of cartilage. Proteoglycans consist of a linker protein along with a core protein to which glycosaminoglycans (GAGs) attach. The most common GAGs are chondroitin sulfate and keratin sulfate. Proteoglycans attach to a central chain, usually hyaluronic acid, via a linker protein, to create larger proteoglycan aggregates. Proteoglycans are hydrophilic and therefore attract and restrain water molecules. This provides cartilage with its intrinsic ability to resist compression. Glycoproteins: Many other glycoproteins are present in cartilage ECM in small amounts that help maintain structure and organization. Specifically, lubricin helps to create a lubricating surface on the cartilage for easier joint mobility.
=== Moisture dependence === The presence of water plays a crucial role in the mechanical behavior of natural fibers. Plants depend on water to help them grow. If the humidity was too high, then it would cause the plants to create mold and bacteria. Humidity would also increase the amount of pests around the plants. Hydrated, biopolymers generally have enhanced ductility and toughness. Water plays the role of a plasticizer, a small molecule easing passage of polymer chains and in doing so increasing ductility and toughness. When using natural fibers in applications outside of their native use, the original level of hydration must be taken into account. For example, when hydrated, the Young's Modulus of collagen decreases from 3.26 to 0.6 GPa and becomes both more ductile and tougher. Additionally the density of collagen decreases from 1.34 to 1.18 g/cm3.
Sources: en.wikipedia.org
It is a synthetic peptide analog of angiotensin IV studied mainly in laboratory and animal research. It is not an approved medicine. Human clinical data are limited.
It is generally not regulated as a dietary supplement. Products are often sold as research chemicals. That status affects purity, labeling, and legal availability.
Dihexa itself is not a standard endogenous peptide. It is synthesized and modeled on angiotensin IV. Angiotensin IV occurs naturally as a fragment of angiotensin II.
The lyophilized powder is commonly kept at -20 °C or lower, protected from moisture and light. Solutions may require colder storage and should avoid repeated freeze-thaw cycles. General peptide stability practices apply.